{"entity":{"type":"insider","cik":"0001443841","url":"/insider/0001443841","json_url":"/insider/0001443841.json","name":"Ciaffoni Joseph","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":40,"n_filings":18,"first":"2018-06-04","last":"2023-12-22","span_basis":"filed_date"},"name_variants":[{"name":"Ciaffoni Joseph","source":"filing","n_filings":18,"first_seen":"2018-06-04","last_seen":"2023-12-22"}],"transactions":[{"id":7803008,"accession":"0001062993-23-023100","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-023100","line_url":"/filing/0001062993-23-023100#line-2","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4357.0,"shares_display":"4,357","price_per_share":30.3825,"price_display":"30.38","price_state":"stated","total_value":132376.5525,"total_display":"132,376.55","total_whole":"132,377","shares_owned_after":275000.0,"shares_owned_after_display":"275,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-21","filed_date":"2023-12-22","scope":"insider"},{"id":8600986,"accession":"0001062993-23-022977","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-23-022977","line_url":"/filing/0001062993-23-022977#line-6","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26454.0,"shares_display":"26,454","price_per_share":30.4003,"price_display":"30.40","price_state":"stated","total_value":804209.5362,"total_display":"804,209.54","total_whole":"804,210","shares_owned_after":275000.0,"shares_owned_after_display":"275,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-20","filed_date":"2023-12-20","scope":"insider"},{"id":8600982,"accession":"0001062993-23-022977","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-23-022977","line_url":"/filing/0001062993-23-022977#line-4","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14516.0,"shares_display":"14,516","price_per_share":30.0318,"price_display":"30.03","price_state":"stated","total_value":435941.6088,"total_display":"435,941.61","total_whole":"435,942","shares_owned_after":275000.0,"shares_owned_after_display":"275,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-19","filed_date":"2023-12-20","scope":"insider"},{"id":8600978,"accession":"0001062993-23-022977","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-022977","line_url":"/filing/0001062993-23-022977#line-2","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27798.0,"shares_display":"27,798","price_per_share":30.0358,"price_display":"30.04","price_state":"stated","total_value":834935.1684,"total_display":"834,935.17","total_whole":"834,935","shares_owned_after":275000.0,"shares_owned_after_display":"275,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-18","filed_date":"2023-12-20","scope":"insider"},{"id":8218712,"accession":"0001062993-23-012809","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-23-012809","line_url":"/filing/0001062993-23-012809","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31272.0,"shares_display":"31,272","price_per_share":21.59836242005628,"price_display":"21.60","price_state":"stated","total_value":675423.9896,"total_display":"675,423.99","total_whole":"675,424","shares_owned_after":276000.0,"shares_owned_after_display":"276,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-02","filed_date":"2023-06-02","scope":"insider","n_lines":2},{"id":8218700,"accession":"0001062993-23-012809","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-23-012809","line_url":"/filing/0001062993-23-012809#line-1","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31272.0,"shares_display":"31,272","price_per_share":22.0887,"price_display":"22.09","price_state":"stated","total_value":690757.8264,"total_display":"690,757.83","total_whole":"690,758","shares_owned_after":306272.0,"shares_owned_after_display":"306,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-01","filed_date":"2023-06-02","scope":"insider"},{"id":8622075,"accession":"0001062993-23-012623","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-012623","line_url":"/filing/0001062993-23-012623#line-2","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31272.0,"shares_display":"31,272","price_per_share":21.8661,"price_display":"21.87","price_state":"stated","total_value":683796.6792,"total_display":"683,796.68","total_whole":"683,797","shares_owned_after":337544.0,"shares_owned_after_display":"337,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-31","filed_date":"2023-06-01","scope":"insider"},{"id":8622073,"accession":"0001062993-23-012623","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-23-012623","line_url":"/filing/0001062993-23-012623#line-1","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31271.0,"shares_display":"31,271","price_per_share":21.9023,"price_display":"21.90","price_state":"stated","total_value":684906.8233,"total_display":"684,906.82","total_whole":"684,907","shares_owned_after":368816.0,"shares_owned_after_display":"368,816","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-30","filed_date":"2023-06-01","scope":"insider"},{"id":8577984,"accession":"0001062993-23-003475","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-23-003475","line_url":"/filing/0001062993-23-003475#line-6","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11250.0,"shares_display":"11,250","price_per_share":26.88,"price_display":"26.88","price_state":"stated","total_value":302400.0,"total_display":"302,400.00","total_whole":"302,400","shares_owned_after":400087.0,"shares_owned_after_display":"400,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-13","filed_date":"2023-02-14","scope":"insider"},{"id":6475274,"accession":"0001062993-22-024500","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-22-024500","line_url":"/filing/0001062993-22-024500","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2204.0,"shares_display":"2,204","price_per_share":23.748003629764064,"price_display":"23.75","price_state":"stated","total_value":52340.6,"total_display":"52,340.60","total_whole":"52,341","shares_owned_after":249150.0,"shares_owned_after_display":"249,150","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-27","filed_date":"2022-12-27","scope":"insider","n_lines":2},{"id":6475269,"accession":"0001062993-22-024500","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-024500","line_url":"/filing/0001062993-22-024500#line-2","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":147.0,"shares_display":"147","price_per_share":23.0,"price_display":"23.00","price_state":"stated","total_value":3381.0,"total_display":"3,381.00","total_whole":"3,381","shares_owned_after":250954.0,"shares_owned_after_display":"250,954","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-23","filed_date":"2022-12-27","scope":"insider"},{"id":6475265,"accession":"0001062993-22-024500","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-024500","line_url":"/filing/0001062993-22-024500#line-1","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":110.0,"shares_display":"110","price_per_share":23.0,"price_display":"23.00","price_state":"stated","total_value":2530.0,"total_display":"2,530.00","total_whole":"2,530","shares_owned_after":251101.0,"shares_owned_after_display":"251,101","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-22","filed_date":"2022-12-27","scope":"insider"},{"id":6536353,"accession":"0001062993-22-024355","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-22-024355","line_url":"/filing/0001062993-22-024355#line-3","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7333.0,"shares_display":"7,333","price_per_share":23.11,"price_display":"23.11","price_state":"stated","total_value":169465.63,"total_display":"169,465.63","total_whole":"169,466","shares_owned_after":251211.0,"shares_owned_after_display":"251,211","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-21","filed_date":"2022-12-21","scope":"insider"},{"id":6536350,"accession":"0001062993-22-024355","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-024355","line_url":"/filing/0001062993-22-024355#line-2","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9375.0,"shares_display":"9,375","price_per_share":23.07,"price_display":"23.07","price_state":"stated","total_value":216281.25,"total_display":"216,281.25","total_whole":"216,281","shares_owned_after":258544.0,"shares_owned_after_display":"258,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-20","filed_date":"2022-12-21","scope":"insider"},{"id":6536347,"accession":"0001062993-22-024355","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-024355","line_url":"/filing/0001062993-22-024355#line-1","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1134.0,"shares_display":"1,134","price_per_share":23.01,"price_display":"23.01","price_state":"stated","total_value":26093.34,"total_display":"26,093.34","total_whole":"26,093","shares_owned_after":267919.0,"shares_owned_after_display":"267,919","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-19","filed_date":"2022-12-21","scope":"insider"},{"id":6350680,"accession":"0001062993-22-023357","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-22-023357","line_url":"/filing/0001062993-22-023357#line-3","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54400.0,"shares_display":"54,400","price_per_share":23.07,"price_display":"23.07","price_state":"stated","total_value":1255008.0,"total_display":"1,255,008.00","total_whole":"1,255,008","shares_owned_after":269053.0,"shares_owned_after_display":"269,053","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-02","filed_date":"2022-12-05","scope":"insider"},{"id":6350677,"accession":"0001062993-22-023357","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-023357","line_url":"/filing/0001062993-22-023357#line-2","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":76653.0,"shares_display":"76,653","price_per_share":22.47,"price_display":"22.47","price_state":"stated","total_value":1722392.91,"total_display":"1,722,392.91","total_whole":"1,722,393","shares_owned_after":323453.0,"shares_owned_after_display":"323,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-01","filed_date":"2022-12-05","scope":"insider"},{"id":6146340,"accession":"0001062993-22-022995","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-022995","line_url":"/filing/0001062993-22-022995#line-2","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43.0,"shares_display":"43","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":946.0,"total_display":"946.00","total_whole":"946","shares_owned_after":323453.0,"shares_owned_after_display":"323,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-28","filed_date":"2022-11-30","scope":"insider"},{"id":6208823,"accession":"0001062993-22-022779","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-022779","line_url":"/filing/0001062993-22-022779#line-2","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65.0,"shares_display":"65","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":1430.0,"total_display":"1,430.00","total_whole":"1,430","shares_owned_after":323453.0,"shares_owned_after_display":"323,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-22","filed_date":"2022-11-25","scope":"insider"},{"id":6322122,"accession":"0001062993-22-022644","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-022644","line_url":"/filing/0001062993-22-022644#line-2","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1989.0,"shares_display":"1,989","price_per_share":22.02,"price_display":"22.02","price_state":"stated","total_value":43797.78,"total_display":"43,797.78","total_whole":"43,798","shares_owned_after":323453.0,"shares_owned_after_display":"323,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-18","filed_date":"2022-11-22","scope":"insider"},{"id":6647272,"accession":"0001062993-22-006644","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-006644","line_url":"/filing/0001062993-22-006644","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":76094.0,"shares_display":"76,094","price_per_share":18.466950745131022,"price_display":"18.47","price_state":"stated","total_value":1405224.15,"total_display":"1,405,224.15","total_whole":"1,405,224","shares_owned_after":335858.0,"shares_owned_after_display":"335,858","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-01","filed_date":"2022-03-03","scope":"insider","n_lines":2},{"id":4771409,"accession":"0001192482-21-000479","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001192482-21-000479","line_url":"/filing/0001192482-21-000479#line-5","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5861.0,"shares_display":"5,861","price_per_share":22.81,"price_display":"22.81","price_state":"stated","total_value":133689.41,"total_display":"133,689.41","total_whole":"133,689","shares_owned_after":267774.0,"shares_owned_after_display":"267,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-02","filed_date":"2021-06-03","scope":"insider"},{"id":4771405,"accession":"0001192482-21-000479","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001192482-21-000479","line_url":"/filing/0001192482-21-000479","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16205.0,"shares_display":"16,205","price_per_share":23.19730021598272,"price_display":"23.20","price_state":"stated","total_value":375912.25,"total_display":"375,912.25","total_whole":"375,912","shares_owned_after":273635.0,"shares_owned_after_display":"273,635","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-03","scope":"insider","n_lines":2},{"id":4980690,"accession":"0001192482-21-000212","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001192482-21-000212","line_url":"/filing/0001192482-21-000212","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":64768.0,"shares_display":"64,768","price_per_share":22.672071702075097,"price_display":"22.67","price_state":"stated","total_value":1468424.74,"total_display":"1,468,424.74","total_whole":"1,468,425","shares_owned_after":288116.0,"shares_owned_after_display":"288,116","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider","n_lines":2},{"id":2089099,"accession":"0001192482-20-000418","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001192482-20-000418","line_url":"/filing/0001192482-20-000418","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5861.0,"shares_display":"5,861","price_per_share":20.48416140590343,"price_display":"20.48","price_state":"stated","total_value":120057.67,"total_display":"120,057.67","total_whole":"120,058","shares_owned_after":192898.0,"shares_owned_after_display":"192,898","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-02","filed_date":"2020-06-02","scope":"insider","n_lines":2},{"id":2089094,"accession":"0001192482-20-000418","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001192482-20-000418","line_url":"/filing/0001192482-20-000418","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70676.0,"shares_display":"70,676","price_per_share":21.53077819910578,"price_display":"21.53","price_state":"stated","total_value":1521709.28,"total_display":"1,521,709.28","total_whole":"1,521,709","shares_owned_after":198759.0,"shares_owned_after_display":"198,759","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-01","filed_date":"2020-06-02","scope":"insider","n_lines":2},{"id":8691005,"accession":"0001192482-19-000392","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001192482-19-000392","line_url":"/filing/0001192482-19-000392","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":64821.0,"shares_display":"64,821","price_per_share":18.771294950710416,"price_display":"18.77","price_state":"stated","total_value":1216774.11,"total_display":"1,216,774.11","total_whole":"1,216,774","shares_owned_after":208681.0,"shares_owned_after_display":"208,681","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-07","filed_date":"2019-11-08","scope":"insider","n_lines":2},{"id":8752376,"accession":"0001192482-19-000274","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001192482-19-000274","line_url":"/filing/0001192482-19-000274#line-3","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7436.0,"shares_display":"7,436","price_per_share":11.59,"price_display":"11.59","price_state":"stated","total_value":86183.24,"total_display":"86,183.24","total_whole":"86,183","shares_owned_after":180222.0,"shares_owned_after_display":"180,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-03","filed_date":"2019-06-04","scope":"insider"},{"id":8752373,"accession":"0001192482-19-000274","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001192482-19-000274","line_url":"/filing/0001192482-19-000274#line-2","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5851.0,"shares_display":"5,851","price_per_share":11.52,"price_display":"11.52","price_state":"stated","total_value":67403.52,"total_display":"67,403.52","total_whole":"67,404","shares_owned_after":190755.0,"shares_owned_after_display":"190,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-31","filed_date":"2019-06-04","scope":"insider"},{"id":6595529,"accession":"0001192482-18-000260","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001192482-18-000260","line_url":"/filing/0001192482-18-000260#line-5","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14862.0,"shares_display":"14,862","price_per_share":22.48,"price_display":"22.48","price_state":"stated","total_value":334097.76,"total_display":"334,097.76","total_whole":"334,098","shares_owned_after":88201.0,"shares_owned_after_display":"88,201","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-01","filed_date":"2018-06-04","scope":"insider"},{"id":6595526,"accession":"0001192482-18-000260","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001192482-18-000260","line_url":"/filing/0001192482-18-000260","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001443841","owner_name":"Ciaffoni Joseph","owner_display_name":"Ciaffoni Joseph","owner_url":"/insider/0001443841","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":64821.0,"shares_display":"64,821","price_per_share":22.610189753320682,"price_display":"22.61","price_state":"stated","total_value":1465615.11,"total_display":"1,465,615.11","total_whole":"1,465,615","shares_owned_after":114885.0,"shares_owned_after_display":"114,885","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-31","filed_date":"2018-06-04","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":40,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":40,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":40},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001267565","name":"COLLEGIUM PHARMACEUTICAL, INC","url":"/issuer/0001267565","role":"Director, Officer (President and CEO)","n_filings":18,"first_seen":"2018-06-04","last_seen":"2023-12-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001443841","retrieved_at":"2026-08-26T15:32:35+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}